For high-grade conventional osteosarcoma, the most frequent bone sarcoma, the data available in the literature is limited to one study, with a cohort of 45 cases showing positivity for PSMA in the neovasculature in 47% of tumors [19]. This evidence concerns the gene FOLH1 and bone sarcoma.